V
Vantis Vascular
Creating advanced tools to enable physicians to treat patients more efficiently and safely
About Vantis Vascular
Vantis Vascular specializes in developing advanced vascular access solutions designed to navigate through complex and calcified arterial pathways. The company serves healthcare providers and medical institutions, focusing on improving the efficacy and safety of vascular procedures. Operating within the medical device market, Vantis Vascular employs a business model centered around the development, manufacturing, and sale of its proprietary catheter systems. Revenue is generated through direct sales to hospitals and clinics, as well as through partnerships with medical device distributors. The company's flagship product features DuoPRO Technology, which allows for smooth traversal through tortuous and calcified arteries, reducing the risk of complications. This technology is particularly beneficial for patients with challenging vascular conditions, offering a reliable and efficient solution for healthcare professionals.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- San Jose, United States
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 54.1/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Catheters, Healthcare Technologies, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Dec 2024 | $10M | $40M | Undisclosed | ↗ |
| EARLY VC✓Equity / VC | May 2024 | $5M | $20M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Vantis Vascular is 2.4K monthly website visits, up 150% over the last three months. Vantis Vascular's team grew 12.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vantis Vascular on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vantis Vascular’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







